Q3 FY2026 · ended Sep 30, 2026 · Revenue $302.25M, +32.0% YoY · Filed Nov 4, 2026
The Pennant Group, Inc. (PNTG) files with the SEC under industry code 8000, Services-Health Services. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $302.3 million and net income of $9.6 million. Free cash flow was $10.1 million. As of Sep 30, 2026 it held $18.4 million in cash and investments and $483.9 million in total debt.
Revenue
$302.25M
+32.0% vs year-ago quarter
Net income
$9.64M
+58.5% vs year-ago quarter
Operating cash flow
$25.12M
+80.4% vs year-ago quarter
Free cash flow
$10.13M
-3.2% vs year-ago quarter
EPS
$0.26
+52.9% vs year-ago quarter
Dividend per share
None
Shares outstanding
35.13M
+1.6% vs year-ago quarter
Net cash
$-465.54M
Q3 FY2026
Operating margin
5.8%
TTM
Company profile
- Industry
- Services-Health Services (SIC 8000)
- Listed as
- PNTG (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Eagle, ID
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1766400
Other Services-Health Services companies
- LifeStance Health Group, Inc. LFST
- Privia Health Group, Inc. PRVA
- GeneDx Holdings Corp. WGS
- U S Physical Therapy Inc /NV USPH
- InnovAge Holding Corp. INNV
- Omada Health, Inc. OMDA
- P3 Health Partners Inc. PIII
- Alps Group Inc ALPS
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $302.3M | $298.0M | $285.4M | $289.3M | $229.0M |
| Operating income | $16.5M | $17.2M | $17.3M | $17.5M | $10.2M |
| Net income | $9.6M | $9.1M | $8.5M | $8.6M | $6.1M |
| Diluted EPS | $0.26 | $0.25 | $0.24 | $0.24 | $0.17 |
| Operating cash flow | $25.1M | $21.8M | -$3.4M | $21.0M | $13.9M |
| Free cash flow | $10.1M | $15.5M | -$8.7M | $17.4M | $10.5M |
| Total assets | $1.0B | $1.0B | $956.5M | $968.2M | $753.6M |
| Total liabilities | $623.1M | $632.8M | $567.0M | $593.9M | $410.6M |
| Stockholders' equity | $419.8M | $404.4M | $389.4M | $374.3M | $343.0M |
| Cash and investments | $18.4M | $15.3M | $4.9M | $17.0M | $2.3M |
| Total debt | $483.9M | $490.6M | $449.1M | $454.8M | $308.8M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 4, 2026 | Nov 4, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 20, 2026 | May 20, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
All 535 The Pennant Group, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.